{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T11:41:16Z","timestamp":1786275676259,"version":"build-2736575974"},"reference-count":34,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Artificial Organs"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Severe thrombocytopenia poses a high risk for bleeding thus representing a relative contraindication for anticoagulation and therefore extracorporeal membrane oxygenation (ECMO). We herein report on a series of immunocompromised patients with severe thrombocytopenia undergoing long\u2010term ECMO without systemic anticoagulation. We retrospectively identified seven adult patients with anticoagulation withdrawal for \u22653 days (range 5\u2013317) during venovenous ECMO therapy due to thrombocytopenia &lt; 50 G\/L treated in a university\u2010affiliated hospital from January 2013 to April 2017. All ECMO systems used were heparin coated. Overall, 530 ECMO days were observed, 404 (76%) of them without systemic anticoagulation. Platelet count during ECMO treatment was 24 G\/L (median, range 1\u2010138), ECMO duration was 35 days (5\u2010317), and ECMO was run without any anticoagulation for 20 days (5\u2010317). Altogether, five clotting events were seen leading to oxygenator exchanges. Bleeding was common including one fatal intracerebral hemorrhage. Altogether, 29 platelet concentrates per patient (7\u2010207) were administered, which correspond to 0.8 per day (0.6\u20101.3). One patient survived ICU and hospital. In patients with thrombocytopenia, ECMO can be run without anticoagulation even for considerably long periods of time. Bleeding remains common, while clotting events seem to be rare. However, prognosis of this patient population undergoing ECMO support seems grim.<\/jats:p>","DOI":"10.1111\/aor.13514","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T10:45:18Z","timestamp":1560336318000},"page":"1077-1084","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["ECMO without anticoagulation in patients with disease\u2010related severe thrombocytopenia: Feasible but futile?"],"prefix":"10.1111","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6103-7884","authenticated-orcid":false,"given":"Alexander","family":"Hermann","sequence":"first","affiliation":[{"name":"Department of Medicine I, Intensive Care Unit 13i2 Medical University of Vienna, General Hospital of Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schellongowski","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Intensive Care Unit 13i2 Medical University of Vienna, General Hospital of Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andja","family":"Bojic","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Intensive Care Unit 13i2 Medical University of Vienna, General Hospital of Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Robak","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Intensive Care Unit 13i2 Medical University of Vienna, General Hospital of Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Buchtele","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Medical University of Vienna, General Hospital of Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Staudinger","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Intensive Care Unit 13i2 Medical University of Vienna, General Hospital of Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2008.08.009"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1089253209347384"},{"key":"e_1_2_8_4_1","volume-title":"ELSO anticoagulation guidelines","author":"The Extracorporeal Life Support Organization (ELSO)","year":"2014"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2010.02.034"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/0267659112457969"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-016-0196-7"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(99)00061-5"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-016-4318-3"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201605-364SR"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002293"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc13701"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0267659111432330"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3957-0"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000000073"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0267659111408634"},{"key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/CCM.0000000000001482","article-title":"Hemostatic changes during extracorporeal membrane oxygenation: a prospective randomized clinical trial comparing three different extracorporeal membrane oxygenation systems","volume":"44","author":"Malfertheiner MV","year":"2016","journal-title":"Crit Care Med."},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016925309136722"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510240069035"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201311-2023OC"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201708-1761OC"},{"key":"e_1_2_8_22_1","volume-title":"Guidelines for adult respiratory failure","author":"The Extracorporeal Life Support Organization (ELSO)","year":"2017"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/aor.12737"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-4015-7"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2010.02.020"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-015-0006-9"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e31824d68e3"},{"key":"e_1_2_8_28_1","first-page":"145","article-title":"Extracorporeal membrane oxygenation in diffuse alveolar hemorrhage secondary to systemic lupus erythematosus","volume":"6","author":"Pacheco Claudio C","year":"2014","journal-title":"J Clin Med Res."},{"key":"e_1_2_8_29_1","first-page":"69","article-title":"Prolonged venovenous extracorporeal membrane oxygenation without anticoagulation: a case of Goodpasture syndrome\u2010related pulmonary haemorrhage","volume":"16","author":"Herbert DG","year":"2014","journal-title":"Crit Care Resusc."},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2014.07.018"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112316"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3312-y"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.2365"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3354-0"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-005-2835-6"}],"container-title":["Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aor.13514","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/aor.13514","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aor.13514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T10:53:12Z","timestamp":1786272792000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aor.13514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1111\/aor.13514"],"URL":"https:\/\/doi.org\/10.1111\/aor.13514","archive":["Portico"],"relation":{},"ISSN":["0160-564X","1525-1594"],"issn-type":[{"value":"0160-564X","type":"print"},{"value":"1525-1594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]},"assertion":[{"value":"2019-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}